We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

84 hedge funds and large institutions have $173M invested in ChemoCentryx, Inc. in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $173M → $173M (-$179K)

6% less funds holding

Funds holding: 8984 (-5)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $89K

Holders
84
Holders Change
-5
Holders Change %
-5.62%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
30
Reduced
26
Closed
11
Calls
Puts
$89K
Net Calls
-$89K
Net Calls Change
-$140K
Name Holding Trade Value Shares
Change
Change in
Stake
EC
26
EcoR1 Capital
California
$859K +$850K +118,000 New
Thrivent Financial for Lutherans
27
Thrivent Financial for Lutherans
Minnesota
$852K +$843K +117,037 New
Bank of America
28
Bank of America
North Carolina
$824K -$326K -45,266 -29%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$784K -$9.89K -1,373 -1%
Federated Hermes
30
Federated Hermes
Pennsylvania
$763K +$91.7K +12,735 +14%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$698K
Russell Investments Group
32
Russell Investments Group
United Kingdom
$686K +$230K +31,997 +51%
ADEF
33
Adams Diversified Equity Fund
Maryland
$640K +$17.3K +2,400 +3%
Goldman Sachs
34
Goldman Sachs
New York
$577K +$151K +20,955 +36%
CFIC
35
City Financial Investment Company
United Kingdom
$566K -$497K -69,001 -47%
BCM
36
Bridgeway Capital Management
Texas
$563K
BIM
37
Bogle Investment Management
Massachusetts
$517K -$244K -33,857 -32%
Ohio Public Employees Retirement System (OPERS)
38
Ohio Public Employees Retirement System (OPERS)
Ohio
$507K
Connor, Clark & Lunn Investment Management (CC&L)
39
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$506K +$180K +24,975 +56%
PCM
40
Piermont Capital Management
Missouri
$484K
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$457K
KeyBank National Association
42
KeyBank National Association
Ohio
$400K
BPC
43
Banque Pictet & Cie
Switzerland
$394K -$151K -21,028 -28%
SO
44
STRS Ohio
Ohio
$382K +$60.5K +8,400 +19%
BBA
45
Baker Bros. Advisors
New York
$357K
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$337K -$7.92K -1,100 -2%
EGA
47
Eagle Global Advisors
Texas
$337K +$334K +46,330 New
SGAM
48
Smith Group Asset Management
Texas
$311K
AA
49
ALPS Advisors
Colorado
$299K -$34.7K -4,815 -10%
American Century Companies
50
American Century Companies
Missouri
$297K +$293K +40,744 New

CCXI Hedge Fund Activity: Q1 2017 in Review

84 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2017, worth a combined $173M — down 0.1% from $173M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CCXI positions and 11 closed out — a net gain of 1 holder — while 30 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Wasatch Advisors, cutting an estimated $2.75M.

  • 84 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2017, down from 89 in Q4 2016.
  • Funds reported $173M of ChemoCentryx, Inc. stock for Q1 2017, down 0.1% quarter-over-quarter.
  • 12 funds opened new ChemoCentryx, Inc. positions in Q1 2017 and 11 closed out, a net change of +1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q1 2017 was BlackRock, an estimated $15.4M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2017 was Wasatch Advisors, an estimated $2.75M sold.

Based on aggregated 13F filings for Q1 2017.